EA200701434A1 - Тауриновый синтез, производство и применение в качестве лекарственного средства - Google Patents
Тауриновый синтез, производство и применение в качестве лекарственного средстваInfo
- Publication number
- EA200701434A1 EA200701434A1 EA200701434A EA200701434A EA200701434A1 EA 200701434 A1 EA200701434 A1 EA 200701434A1 EA 200701434 A EA200701434 A EA 200701434A EA 200701434 A EA200701434 A EA 200701434A EA 200701434 A1 EA200701434 A1 EA 200701434A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- taurine
- hyperlipidemia
- medicine
- manufacture
- add
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EG2005010013 | 2005-01-05 | ||
PCT/EG2005/000044 WO2006072259A2 (en) | 2005-01-05 | 2005-12-31 | Taurine synthesis, production and utility as a medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200701434A1 true EA200701434A1 (ru) | 2008-10-30 |
Family
ID=36647837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200701434A EA200701434A1 (ru) | 2005-01-05 | 2005-12-31 | Тауриновый синтез, производство и применение в качестве лекарственного средства |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1844006A2 (pt) |
JP (1) | JP2008526789A (pt) |
KR (1) | KR20070091198A (pt) |
CN (1) | CN101146767A (pt) |
AP (1) | AP2007004084A0 (pt) |
AU (1) | AU2005324199A1 (pt) |
BR (1) | BRPI0519606A2 (pt) |
CA (1) | CA2593563A1 (pt) |
EA (1) | EA200701434A1 (pt) |
IL (1) | IL184221A0 (pt) |
MA (1) | MA29238B1 (pt) |
MX (1) | MX2007008196A (pt) |
NO (1) | NO20074937A (pt) |
TN (1) | TNSN07226A1 (pt) |
WO (1) | WO2006072259A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2706768C (en) | 2007-11-30 | 2016-06-28 | The Regents Of The University Of California | Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
CN103382170B (zh) * | 2012-10-25 | 2015-04-08 | 潜江永安药业股份有限公司 | 一种牛磺酸的制备方法 |
CN106728405A (zh) * | 2016-11-15 | 2017-05-31 | 陈思文 | 一种牛磺酸和水溶性茶多酚复方组合物及其制备方法与应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58140017A (ja) * | 1981-12-22 | 1983-08-19 | Junichi Azuma | 心不全治療剤 |
JPH08208464A (ja) * | 1994-12-02 | 1996-08-13 | Taisho Pharmaceut Co Ltd | 高脂血症の治療及び予防薬 |
US6184227B1 (en) * | 1995-07-21 | 2001-02-06 | Savvipharm Inc. | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
SE9601395D0 (sv) * | 1996-04-12 | 1996-04-12 | Dieter Haeussinger | New therapeutic treatment 1 |
GB9722361D0 (en) * | 1997-10-24 | 1997-12-17 | Pharma Nord Uk Ltd | Pharmaceutical formulation for treating liver disorders |
NZ527924A (en) * | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
WO2001026642A2 (en) * | 1999-10-08 | 2001-04-19 | Joyce Corinne Bechthold | Methods and compositions for treating neurobehavioral disorders |
CN1340502A (zh) * | 2000-06-30 | 2002-03-20 | 张永春 | 牛磺酸合锌的生产工艺 |
CN1268733C (zh) * | 2004-07-20 | 2006-08-09 | 刘辉 | 牛磺酸功能啤酒及其生产工艺 |
-
2005
- 2005-12-31 CN CNA2005800460663A patent/CN101146767A/zh active Pending
- 2005-12-31 KR KR1020077016443A patent/KR20070091198A/ko not_active Application Discontinuation
- 2005-12-31 CA CA002593563A patent/CA2593563A1/en not_active Abandoned
- 2005-12-31 AP AP2007004084A patent/AP2007004084A0/xx unknown
- 2005-12-31 BR BRPI0519606-0A patent/BRPI0519606A2/pt not_active IP Right Cessation
- 2005-12-31 MX MX2007008196A patent/MX2007008196A/es not_active Application Discontinuation
- 2005-12-31 AU AU2005324199A patent/AU2005324199A1/en not_active Abandoned
- 2005-12-31 EA EA200701434A patent/EA200701434A1/ru unknown
- 2005-12-31 WO PCT/EG2005/000044 patent/WO2006072259A2/en active Application Filing
- 2005-12-31 EP EP05818935A patent/EP1844006A2/en not_active Withdrawn
- 2005-12-31 JP JP2007549796A patent/JP2008526789A/ja active Pending
-
2007
- 2007-06-14 TN TNP2007000226A patent/TNSN07226A1/fr unknown
- 2007-06-26 IL IL184221A patent/IL184221A0/en unknown
- 2007-07-26 MA MA30110A patent/MA29238B1/fr unknown
- 2007-09-28 NO NO20074937A patent/NO20074937A/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1844006A2 (en) | 2007-10-17 |
AU2005324199A1 (en) | 2006-07-13 |
CA2593563A1 (en) | 2006-07-13 |
JP2008526789A (ja) | 2008-07-24 |
BRPI0519606A2 (pt) | 2009-02-25 |
WO2006072259A3 (en) | 2007-10-04 |
IL184221A0 (en) | 2008-12-29 |
NO20074937A (no) | 2007-09-28 |
TNSN07226A1 (en) | 2008-11-21 |
KR20070091198A (ko) | 2007-09-07 |
MA29238B1 (fr) | 2008-02-01 |
CN101146767A (zh) | 2008-03-19 |
MX2007008196A (es) | 2008-02-22 |
WO2006072259A2 (en) | 2006-07-13 |
AP2007004084A0 (en) | 2007-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3192506A3 (en) | Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient | |
PE20140389A1 (es) | Composiciones y metodos para el tratamiento de la mielofibrosis | |
DK1885187T3 (da) | Fremgangsmåde til behandling af lægemiddelresistent cancer | |
TW200745052A (en) | Thyroid hormone receptor agonists | |
RS20080533A (en) | Triazolopyrazine derivatives useful as anticancer agents | |
EA200401136A1 (ru) | Предназначенная для перорального применения лекарственная форма для этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1h-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и его солей | |
MX2010002675A (es) | Profarmacos para analogos de hormonas tiroideas. | |
EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
EA201070572A1 (ru) | Модуляция транспорта белков | |
NO20085217L (no) | Effektive pyrimidinderivater i behandlingen av kreft | |
MA34819B1 (fr) | Dérivés bicyclo[3.2.1]octylamide et leurs utilisations | |
TW200637839A (en) | 1-thio-d-glucitol derivatives | |
EA200970726A1 (ru) | Твердый препарат, содержащий алоглиптин и пиоглитазон | |
MY151295A (en) | Pyrimidyl indoline compound | |
EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
DK1750703T3 (da) | Fremgangsmåde til at reducere gastrointestinal toksitet forårsaget af indgivelsen af tegafur | |
NZ600390A (en) | Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
WO2008109991A8 (en) | Inhibitors of carnitine palmitoyltransferase and treating cancer | |
EA200701434A1 (ru) | Тауриновый синтез, производство и применение в качестве лекарственного средства | |
MY163762A (en) | Therapeutic agent for chronic renal failure | |
EA200800075A1 (ru) | Схема дозирования для празугреля | |
UA122762C2 (uk) | Пероральна композиція 9-[(2,2-диметилпропіламіно)-метил]-міноцикліну або його солі, тверда пресована дозована форма, композиція для ін'єкцій, застосування та спосіб приготування фармацевтичної композиції | |
EA200800464A1 (ru) | Фармацевтическая композиция, содержащая периндоприл или его соли | |
ATE410152T1 (de) | Therapeutisches system mit amoxicillin und clavulansäure |